Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glivec in Pediatric CML
NCT00845221Phase 4Completed
- Sponsor
- CHU de Poitiers
- Start
- Jul 2004
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of imatinib in chronic myeloid leukemia (CML), sponsored by CHU de Poitiers. Started Jul 2004; status: completed.
02
Drugs
03
Conditions
chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT00845221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00845221.